This is unpublished

Laura M.
Dember
M.D.

Laura Dember, MD
Scientific Advisory Committee
Pinned
Academic
Professor of Medicine (Renal-Electrolyte and Hypertension), University of Pennsylvania
Professor of Epidemiology in Biostatistics and Epidemiology
Professional
Director, Clinical Research Certificate Program, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania
Sites of Practice
Perelman School of Medicine, University of Pennsylvania

Contact

Renal-Electrolyte and Hypertension Division
University of Pennsylvania Perelman School of Medicine
Center for Clinical Epidemiology and Biostatistics
Blockley Hall, Office 920
423 Guardian Drive
Philadelphia, PA 19104

P: 215-573-5264
F: 215-615-0349
E: ldember@pennmedicine.upenn.edu

Education and Training

MEDICAL SCHOOL
Yale University

RESIDENCY
Hospital of the University of Pennsylvania

FELLOWSHIP
Hospital of the University of Pennsylvania
Brigham and Women's Hospital

Research Interests

Dr. Dember conducts patient-oriented research including mechanistic studies and clinical trials in chronic kidney disease and end-stage renal disease (ESRD). She has held leadership roles in several multicenter clinical trials and observational studies including the Dialysis Access Consortium, the Hemodialysis Fistula Maturation Study, the Hemodialysis Novel Therapies Consortium, the Chronic Renal Insufficiency Cohort study, and the HOPE Consortium trial, all funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). As the Principal Investigator for the NIH Time to Reduce Mortality in End-Stage Renal Disease trial (TiME), Dr. Dember played an important role in introducing to the Nephrology community large pragmatic trials embedded in clinical care delivery, an effort that she is continuing as a Co-Investigator for the NIDDK HiLo trial and as Multiple PI for the PCORI-funded SMaRRT-HD Study. She is currently serving as the Principal Investigator for the Data Coordinating Center for the HOPE Trial, the CRIC Study, and the SMaRRT-HD Study.